%0 Journal Article %A Elisabetta Colosi %A Giulia Bassignana %A Diego Andrés Contreras %A Canelle Poirier %A Simon Cauchemez %A Yazdan Yazdanpanah %A Bruno Lina %A Arnaud Fontanet %A Alain Barrat %A Vittoria Colizza %T Self-testing and vaccination against COVID-19 to minimize school closure %D 2021 %R 10.1101/2021.08.15.21261243 %J medRxiv %P 2021.08.15.21261243 %X Schools were largely closed in 2020-2021 to counter COVID-19 spread, impacting students’ education and well-being. With highly contagious variants expanding in Europe while vaccine hesitancy persists, safe options to maintain schools open are urgently needed. We developed an agent-based model of SARS-CoV-2 transmission in school. We used empirical contact data measured in a primary and a secondary school in France, and field estimates for adherence to screening from 683 schools during the spring 2021 wave. Examining different screening protocols, we performed a cost-benefit analysis for varying epidemic conditions and vaccination scenarios. In a partially immunized school population, weekly screening would reduce the number of cases on average by 24% in the primary and 53% in the secondary school compared to symptom-based testing alone, if R=1.3 and 50% adhered to screening. This adherence was met in primary schools (53% (95% confidence interval 21-85%)), but insufficient participation was recorded in secondary schools (10% (1-38%) in middle schools, 6% (2-12%) in high schools). Regular screening would also reduce by 90% the number of student-days lost compared to reactive class closure. No difference was predicted when fully vaccinating teachers, due to their limited number and mixing. Partially vaccinating adolescents would still require regular screening for additional control (20% case reduction with 50% vaccinated students). In the upcoming fall, COVID-19 epidemic will likely continue to pose a risk to the safe opening of schools. Increasing vaccination coverage in adolescents and implementing regular testing while largely incentivizing adherence are essential steps to keep schools open.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partially funded by: ANR projects COSCREEN (ANR-21-CO16-0005) and DATAREDUX (ANR-19-CE46-0008-03); EU H2020 grants MOOD (H2020- 874850) and RECOVER (H2020-101003589); REACTing COVID-19 grantAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Contact studies were approved by the Commission Nationale de l'Informatique et des Libert&;eacutes (CNIL, the French national body responsible for ethics and privacy) and school authorities. Informed consent was obtained from participants or their parents if minors. No personal information of participants was associated with the RFID identifier. Testing at school was part of surveillance activities approved by school authorities and proposed with parental consent. Data on adherence to screening were aggregated and anonymized at school level.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available at the references cited. %U https://www.medrxiv.org/content/medrxiv/early/2021/08/21/2021.08.15.21261243.full.pdf